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Aim. To identify risk factors for urticaria, to determine the relative proportion of the susceptibility to urticaria that is due to genetic
factors in an adult clinical twin sample, and to further determine whether the genetic susceptibility to urticaria overlaps with the
genetic susceptibility to atopic diseases. Methods. A total of 256 complete twin pairs and 63 single twins, who were selected from
sibships with self-reported asthma via a questionnaire survey of 21,162 adult twins from the Danish Twin Registry, were clinically
interviewed about a history of urticaria and examined for atopic diseases. Data were analysed with Cox proportional hazards
regression and variance components models. Results. A total of 151 individuals (26%) had a history of urticaria, whereas 24 (4%)
had had symptoms within the past year. Female sex, HR = 2.09 (1.46–2.99), P = 0.000; hay fever, HR = 1.92 (1.36–2.72),
P = 0.000; and atopic dermatitis, HR = 1.44 (1.02–2.06), P = 0.041 were significant risk factors for urticaria. After adjustment
for sex and age at onset of urticaria in the index twin, the risk of urticaria was increased in MZ cotwins relative to DZ cotwins,
HR = 1.42 (0.63–3.18), P = 0.394. Genetic factors explained 45% (16–74%), P = 0.005, of the variation in susceptibility to
urticaria. The genetic correlation between urticaria and hay fever was 0.45 (0.01–0.89), P = 0.040. Conclusions. Susceptibility to
urticaria is partly determined by genetic factors. Urticaria is more common in women, and in subjects with hay fever and atopic
dermatitis, and shares genetic variance with hay fever.
1. Introduction
Urticaria is a common complex disease characterised by
disseminated or local eruption of migrating itching wheals
sometimes complicated by swelling of mucosal membranes;
angioedema. Urticaria carries a lifetime risk of about 20%
and is a troublesome disease that significantly impacts
on quality of life. The mainstay of treatment of urticaria
is nonsedating antihistamines. However, in many patients
treatment with immunosuppressive drugs such as corticos-
teroids, azathioprine, cyclosporine, and biological therapies
is necessary in order to obtain symptomatic control [1, 2].
Urticaria can be divided into acute and chronic types
arbitrarily based on whether symptoms have been present
for more than six weeks. Acute urticaria is usually triggered
by allergic reactions to foods, insect venoms, or drugs, or
it can be triggered by infections. However, in many cases
the cause remains unknown. Likewise, chronic urticaria can
be classified into several clinical and aetiological subtypes
of for example allergic, autoimmune, physical, or idiopathic
origin. Particularly, chronic urticaria that has no detectable
cause is termed chronic idiopathic urticaria, whereas chronic
autoimmune urticaria is present in those with antibodies
against the high-aﬃnity IgE receptor (FcεRI) on mast cells
and basophils [3].
Genetic studies of urticaria have shown very diverse
results, in part due to the heterogeneous nature of the
disease. Notably, polymorphisms in multiple genes such as
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the TNF-alpha promoter, the IL18, the thromboxane A2
receptor, the leukotriene C4 synthase, and the FcεRI genes,
have been associated with aspirin-sensitive urticaria [4–9].
Moreover, studies have associated several variants in the
HLA, the FPRL1 promoter, and the TGF-beta1 promoter
and cyclo-oxygenase and 5-lipo-oxygenase-activating pro-
tein genes, with chronic urticaria [10–14]. Finally, hereditary
angioedema has an obvious genetic cause being transmitted
autosomal dominantly (disease types I and II) via mutations
in the C1NH gene; disease type III is more heterogeneous
and is caused by mutations in the Factor XII gene [15].
Taken together, these findings suggest a genetic component
in the pathogenesis of several urticaria subtypes. However, to
what extent genetic factors account for variation in overall
urticaria susceptibility is less well-determined. One previous
twin study of 1480 Swedish children, 7–9 years of age, found a
heritability of urticaria of 54% in boys and 60% in girls [16].
However, the urticaria diagnosis relied on questionnaire
responses and was not confirmed by clinical examination.
We identified risk factors for urticaria and determined
the relative proportion of the susceptibility to urticaria
that was due to genetic factors in an adult clinical twin
sample selected from sibships with self-reported asthma.
Furthermore, we studied whether the genetic susceptibility
to urticaria overlaps with the genetic susceptibility to atopic
diseases.
2. Methods
2.1. Study Population. The sample consisted of twins born
between 1953 and 1982, who were registered in the nation-
wide Danish Twin Registry [17]. A total of 21,162 twin
individuals, 20–49 years of age, answered a questionnaire
concerning health and lifestyle. The response rate was 75%.
Of these, 7,317 twin pairs were intact and 6,528 subjects
were single responders. In total 6,791 pairs had known
zygosity (33% monozygotic (MZ) twins, and 67% dizygotic
(DZ) twins) and complete data on asthma. Among these,
438 pairs who lived in the geographical region surrounding
the study site, and of whom at least one proband had
self-reported asthma based on an aﬃrmative response to a
screening question, were invited to take part in a clinical
examination. The examination included an interview and
paraclinical tests for allergy (measurement of serum total
IgE and skin prick test for common aeroallergens). The
asthma-screening question was “Do you have, or have you
ever had asthma?” Twin zygosity was determined using
four questions of similarity between the twins, which assign
zygosity correctly in more than 95% of the cases [18]. The
Scientific Ethics Committee of Copenhagen approved the
study.
2.2. Clinical Interview. At the clinical interview, subjects
were asked about a lifetime history of urticaria, age at
first episode, presence of symptoms within the past year,
and current symptoms. Specific questions were “Have
you ever had nettle rash/hives/urticaria?,” “Have you had
nettle rash/hives/urticaria within the past year?,” “How
old were you when you got nettle rash/hives/urticaria?”
The interviewing physician explained symptoms of nettle
rash/hives/urticaria and made sure that each patient under-
stood the term and provided as qualified an answer as
possible. In cases of doubt, photographic material was used
as diagnostic aid. Bymeans of similar questions subjects were
also asked about the presence of asthma [19], hay fever [20],
and atopic dermatitis [21].
2.3. Skin Prick Test and Measurement of Serum Total IgE.
Skin prick tests were performed using standard dilutions
birch, grass, mugwort, horse, dog, cat, house dust mite (Der-
matophagoides pteronyssinus and Dermatophagoides farinae),
and mould (Alternaria iridis and Cladosporium herbarium)
allergens (Soluprick SQ system; ALK-Abello´, Denmark).
Reactions were read after 15 minutes. A positive result
was defined as a positive reaction to at least one of the
allergens, and a reaction was considered positive if the
mean wheal diameter was at least 3mm. Serum total IgE
was measured with an enzyme-linked immunosorbent assay
(ELISA) on Immulite 2500 (DPC, New York, USA). Results
were expressed as KIU/L.
2.4. Statistical Analysis. First, risk factors for urticaria were
determined with a Cox proportional hazards regression
model with age as the underlying time ignoring the familial
relationships between the twins. Covariates were sex, BMI,
zygosity, asthma, hay fever, atopic dermatitis, smoking ever,
positive skin prick test, and serum total IgE. Next, a Cox
proportional hazards regression model was fitted with the
time to onset of urticaria in the cotwin of an aﬀected twin
(the index twin) as the underlying time, and zygosity, sex,
and age at onset of urticaria in the index twin as covariates.
In this analysis an increased hazard ratio (HR) in MZ twins
relative to DZ twins would signal a genetic susceptibility to
urticaria. Regression analyses were performed in SPSS 16.0
(SPSS, Inc., Chicago, IL, USA).
Using the classical twin method [22], the variation in the
susceptibility to urticaria was partitioned into components
representing latent genetic and environmental factors with
sex as covariate. Subsequently, bivariate variance compo-
nents analyses were performed between urticaria and atopic
diseases. These bivariate analyses allow one to test to what
extent the correlation between diseases is of genetic or
environmental origin [23]. Variance components analyses
were performed in the statistical package SOLAR, in which
estimates are adjusted for ascertainment due to the selection
in this study through a twin proband with asthma.
3. Results
A total of 575 subjects (256 intact pairs; 89 MZ pairs, 167
DZ pairs, and 63 single twins) underwent the clinical exam-
ination (individual response rate 67%; pair-wise response
rate 60%). Characteristics of the studied subjects are given
in Table 1. The mean age was 36 years, 58% of the subjects
were females, and 46% had a history of smoking.
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Table 1: Descriptive characteristics of a sample of 575Danish twins,
20–51 years of age.
N (%)
Demographic data
Age 35.9 (8.2)
Males 240 (41.7)
Females 335 (58.3)
MZ twins 191 (33.2)
DZ twins 384 (66.8)
BMI 25.3 (4.6)
Smoking ever 262 (45.6)
Clinical traits
Urticaria ever 151 (26.3)
Urticaria in the past 12 months 24 (4.2)
Urticaria currently 0 (0)
Asthma 337 (58.6)
Hay fever 309 (53.7)
Atopic dermatitis 137 (23.8)
Paraclinical traits
Positive skin prick test 318 (55.3)
Serum total IgE 54.4 (4.3)
MZ: monozygotic; DZ: dizygotic; BMI: body mass index.
All numbers are prevalence (%) except age (years, mean); BMI (kg/m2,
mean); and serum total IgE (KIU/L, geometric mean).
A total of 151 (26.3%) of the population; 43 (17.9%) of
the men and 108 (32.2%) of the women had a history of
urticaria, whereas 24 (4.2%); 6 (2.5%) of the men and 18
(5.4%) of the women had had symptoms within the past year.
None of the subjects had urticaria at the day of examination.
Among subjects with a history of urticaria, the median age at
onset was 18.6 years (Figure 1). After proportional hazards
regression, female sex, HR= 2.09 (1.46–2.99), P = 0.000;
hay fever, HR= 1.92 (1.36–2.72), P = 0.000; and atopic
dermatitis, HR= 1.44 (1.02–2.06), P = 0.041 were retained
as significant risk factors for urticaria (Table 2).
Figure 2 shows the risk of urticaria in the cotwin of an
aﬀected twin for MZ and DZ twins separately, as a function
of age of onset in the index twin. After adjustment for sex
and age at onset of urticaria in the index twin, the risk
of urticaria was increased in MZ cotwins relative to DZ
cotwins, HR= 1.42 (0.63–3.18), P = 0.394, indicating that
the variation in the susceptibility to urticaria is of genetic
origin (Table 3). As this regression analyses only built on 34
MZ and 73 DZ twin pairs of whom 10 and 16, respectively,
were concordant for urticaria, we proceeded with variance
components analysis, which was based on the data of all
twins in the sample.
Variance components analysis showed that genetic fac-
tors explained 45% (16–74%), P = 0.005 of the variation
in susceptibility to urticaria, 64% (33–95%), P = 0.000 of
atopic dermatitis, 40% (24–56%), P = 0.000 of hay fever,
and 25% (13–37%), P = 0.000 of asthma. The genetic and
environmental correlations, respectively, between urticaria
and atopic dermatitis were −0.06 (−0.58–0.46), P = ns
and 0.23 (−0.32–0.78), P = ns; between urticaria and hay
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Figure 1: Cumulative incidence proportion of urticaria among all
aﬀected patients.
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Figure 2: Risk of urticaria in the cotwin of an aﬀected twin.
Note: Full line represents monozygotic twins; dotted line represents
dizygotic twins. Log rank P = 0.260.
fever were 0.45 (0.01–0.89), P = 0.040 and −0.15 (−0.16–
0.47), P = ns; and between urticaria and asthma were −0.07
(−0.62–0.49), P = ns and −0.22 (−0.78–0.34), P = ns,
indicating that urticaria shares some genetic variance with
hay fever, but not with atopic dermatitis and asthma.
4. Discussion
This study provides one among just a few available estimates
of the heritability of urticaria and to our knowledge is the
only clinical investigation of the heritability of the disease;
genetic factors were found to explain about half of the
variation in the susceptibility to urticaria, whereas the other
half could be ascribed to random nongenetic variation.
The lifetime prevalence of urticaria in the population was
26%, whereas the 12-month prevalence was 4%. The disease
was about two times more common in women than in
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Table 2: Predictors of urticaria in a sample of 575 Danish twins, 20–51 years of age.
Urticaria diﬀerence (%) Crude HR (95% CI) P value Adjusted HR (95% CI) P value
Sex 14.3 1.96 (1.39–2.80) 0.000 2.09 (1.46–2.99) 0.000
BMI 0.2 0.98 (0.94–1.02) 0.249 ns
Zygosity 1.7 1.01 (0.72–1.42) 0.963 ns
Smoking ever 4.1 0.81 (0.58–1.11) 0.192 ns
Asthma 9.7 1.60 (1.14–2.25) 0.007 ns
Hay fever 13.9 1.93 (1.38–2.71) 0.000 1.92 (1.36–2.72) 0.000
Atopic dermatitis 10.6 1.63 (1.15–2.30) 0.006 1.44 (1.02–2.06) 0.041
Positive skin prick test 7.4 1.45 (1.04–2.01) 0.028 ns
Serum total IgE 19.2 1.31 (1.03–1.68) 0.031 ns
Urticaria diﬀerence is the absolute diﬀerence in prevalence between exposure groups; for example for sex the diﬀerence in the prevalence of urticaria between
males and females is 14.3%. All numbers are (%) except BMI (diﬀerence in mean BMI between urticaria patients and non-urticaria patients) and serum total
IgE (diﬀerence in mean serum total IgE (log-transformed) between urticaria patients and non-urticaria patients).
HR: hazard ratio; CI: confidence interval; BMI: body mass index. Adjusted HR is multivariably adjusted.
Table 3: Predictors of urticaria in the co-twin of an aﬀected twin,
in twin pairs, 20–51 years of age.
Crude HR
P value
Adjusted HR
P value
(95% CI) (95% CI)
Zygosity
DZ 1.00 1.00
MZ 1.57 (0.71–3.47) 0.267 1.42 (0.63–3.18) 0.394
Sex
Males 1.00 1.00
Females 1.86 (0.78–4.44) 0.160 1.86 (0.78–4.45) 0.165
Age at onset 0.98 (0.93–1.03) 0.328 0.98 (0.93–1.03) 0.346
DZ: dizygotic twins; MZ: monozygotic twins. HR: hazard ratio; CI:
confidence interval. Adjusted HR is multivariably adjusted.
men and in subjects with hay fever and atopic dermatitis.
Furthermore, urticaria was found to share genetic variance
with hay fever, but not with atopic dermatitis or asthma.
One of the clear strengths of this study is the systematic
selection of subjects from a nationwide population of twins,
and the subsequent collection of detailed clinical interview
data on 575 adults. Urticarial rash is transient and is therefore
often not present at the day of examination. Therefore,
the diagnosis relies chiefly on patient recollection and on
the capability of the interviewing physician to obtain the
correct information about past symptoms. Although we
collected data on the lifetime history of urticaria, we did not
obtain information on the duration and specific exposures
relating to the occurrence of symptoms, which limits our
ability to distinguish between diﬀerent subtypes of disease.
Particularly, we had no information on food allergy, allergy
to medications, or other factors that could have aided in
the aetiological workup. Also, we did not record whether
urticaria episodes were accompanied by allergic reactions
such as angioedema, acute gastroenteritis, airway symptoms,
or anaphylaxis. Neither did we record whether the subjects
had had several or just one episode of the disease. Common
physical urticarias such as symptomatic dermographism,
delayed pressure urticaria and cholinergic urticaria, and
chronic spontaneous urticaria are entirely diﬀerent der-
matoses which all manifest as clinically diﬀerent types of
hives. The nature and importance of genetic factors will
predictably diﬀer in these diverse subtypes. Unfortunately
the clinical interview did not allow discrimination between
these diﬀerent forms of chronic urticaria. However, a large
proportion of the studied subjects had known type 1 allergy
and associated atopic disorders, which makes it likely that
their episodes of urticaria had an allergic basis. We therefore
consider the main type of urticaria encountered in our
population acute type 1 allergy-mediated urticaria and not
chronic urticaria. This was also supported by our finding
that the 12-month and current prevalence of the disease was
much lower than the cumulative lifetime prevalence, and that
the cumulative lifetime prevalence in this population with
atopic predisposition was slightly higher than what could be
expected in the general population. Our results may therefore
only be applicable to an allergic population and not to the
population as a whole, although we used statistical methods
to correct for this skewed ascertainment of individuals.
Urticaria and hay fever were genetically correlated to
a sizable extent; 0.45. Interestingly, in congruence with
our finding, the genetic correlation between urticaria and
hay fever was also exactly 0.45 among Swedish children
[16]. In contrast, however, we did not find a significant
genetic correlation between urticaria and atopic dermatitis
or asthma, which is contradictory to the findings among
Swedish children in whom the genetic correlation between
urticaria and atopic dermatitis was 0.48, and the genetic
correlation between urticaria and asthma was 0.48.
However, the Swedish study was based on questionnaire
responses while our study was based on confirmed clini-
cal examination. A recent finding among a Han Chinese
population showed that polymorphisms in the high aﬃnity
receptor of IgE are associated with atopic dermatitis but
not with urticaria, indicating that these diseases may have
diﬀerent genetic aetiologies, at least in respect to certain
genetic polymorphisms [24].
We conclude that the susceptibility to urticaria is deter-
mined partly by genetic factors. Notably, half of all variance
of urticaria susceptibility is ascribable to diﬀerences between
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subjects on a genetic level. Moreover, urticaria is more
common in women and in subjects with hay fever and
atopic dermatitis and has overlapping genetic features with
hay fever. Future genetic studies distinguishing diﬀerent
subphenotypes of urticaria (e.g., chronic autoimmune or
chronic idiopathic urticaria) could contribute to further
unravelling of the aetiology of the disease.
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